Prognostic utility of lipoprotein(a) combined with fibrinogen in patients with stable coronary artery disease: a prospective, large cohort study

BACKGROUND: Elevated lipoprotein(a) [Lp(a)] and fibrinogen (Fib) are both associated with coronary artery disease (CAD). The atherogenicity of Lp(a) can be partly due to the potentially antifibrinolytic categories. We hypothesize that patients with higher Lp(a) and Fib may have worse outcomes. METHO...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:J Transl Med
Huvudupphovsmän: Zhang, Yan, Jin, Jing-Lu, Cao, Ye-Xuan, Liu, Hui-Hui, Zhang, Hui-Wen, Guo, Yuan-Lin, Wu, Na-Qiong, Gao, Ying, Hua, Qi, Li, Yan-Fang, Xu, Rui-Xia, Cui, Chuan-Jue, Liu, Geng, Dong, Qian, Sun, Jing, Li, Jian-Jun
Materialtyp: Artigo
Språk:Inglês
Publicerad: BioMed Central 2020
Ämnen:
Research
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC7528376/
https://ncbi.nlm.nih.gov/pubmed/33004038
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12967-020-02546-y
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk